Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Analytics

Biotechnology

Health & Wellness

Information Technology

Helix

James Lu

Sheren Chiang

Stefano Menti

Leslie Liang

Sarah Bobulsky

Sharoni Jacobs

Jim Chou 

Craig Newman

Will Lee

Kirsten Mouritsen

Rebecca Schapiro 

Elissa Levin

Gloria Lee

The board of directors at Helix is made up of individuals with a diverse range of experiences and backgrounds. Some members have experience working in sales for Helix Impressions, while others have a background in finance from Sheridan College. Other members have experience working in transportation with Dicom Transportation Group Canada Inc. No matter their individual backgrounds, the board of directors at Helix is committed to working together to make the company successful.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Helix

Leadership Team

CEO and Executive Team